MRSA and MRSE: Is there an answer

Clinical Microbiology and Infection

Volumn 6, Issue SUPPL. 2, 2000, Pages 17-22

  Carbon, C ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Antibiotics; Infection control; Intensive care units; Methicillin resistance; Multidrug resistance; Nosocomial infection; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin

Indexed keywords

ANTIINFECTIVE AGENT; GLYCOPEPTIDE;

CROSS INFECTION; DRUG EFFECT; HUMAN; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; GLYCOPEPTIDES; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0348019078     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00005.x     Document Type: Article

References (4)

1. Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-89. National Nosocomial Infections Surveillance System. Am J Med 1991; 91 (Suppl. 3B): S86-9.
2. Huebner J, Goldmann DA. Coagulase-negative staphylococci: role as pathogens. Ann Rev Med 1999; 50: 223-36.
3. Caputo GM, Archer GL, Calderwood SB, DiNubile MJ, Karchmer AW. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med 1987; 83: 619-25.
4. Vincent JJL, Bihari DJ, Suter FM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274: 639-44.